BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 19034865)

  • 1. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
    Fabrizi F; Lunghi G; Messa P; Martin P
    J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection and glomerular disease.
    Fabrizi F; Donato F; Messa P
    Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
    Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P
    Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis.
    Sansonno D; Gesualdo L; Manno C; Schena FP; Dammacco F
    Hepatology; 1997 May; 25(5):1237-44. PubMed ID: 9141444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiviral therapy on hepatitis C virus related glomerulopathy.
    Abbas G; Hussain S; Shafi T
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):775-80. PubMed ID: 18711294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.
    Feng B; Eknoyan G; Guo ZS; Jadoul M; Rao HY; Zhang W; Wei L
    Nephrol Dial Transplant; 2012 Feb; 27(2):640-6. PubMed ID: 21558431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
    Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
    Korte MR; van Heerde MJ; de Man RA; Betjes MH
    Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases].
    Ben Fatma L; Ben Hamida F; Aoudia R; Goucha R; Kaaroud H; Béji S; Barbouch S; Hedri H; Abderrahim E; Elyounsi F; Ben Abdallah T; Ben Moussa F; Kheder A
    Tunis Med; 2007 Mar; 85(3):220-4. PubMed ID: 17668578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
    Staak JO; Glossmann JP; Diehl V; Josting A
    Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
    Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN
    Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C virus and kidney: a strong association with different clinical aspects.
    Pipili C; Ilonidis G; Cholongitas E
    Liver Int; 2011 Sep; 31(8):1071-80. PubMed ID: 21745269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
    Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis.
    De Nicola S; Aghemo A; Campise MR; D'Ambrosio R; Rumi MG; Messa P; Colombo M
    Antivir Ther; 2014; 19(5):527-31. PubMed ID: 24009104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
    Terrault NA; Adey DB
    Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.